Retour
Healios KK (HLOSF) Prix
Graphique du cours de l'action HLOSF
HLOSF Prix
Healios KK
$2.7
0%
$0
À partir d'aujourd'hui :Mar 24, 14:23:35 GMT-4
Statistiques clés
Clôture préc.
$2.7
Prix d'ouverture
$2.7
Plage de la journée
$2.7 - $2.7
Plage de 52 semaines
$1.9 - $4.45
Volume
100
Volume moyen
20
Rendement en dividend
--
BPA (TTM)
-0.17
Capitalisation boursière
$364.5M
Qu’est-ce que HEALIOS K K ?
Healios KK engages in the research, development, and sale of cellular and regenerative medicine. The company is headquartered in Chiyoda-Ku, Tokyo-To. The company went IPO on 2015-06-16. The somatic stem cell regenerative medicine field develops and markets cell therapy drugs for acute stroke and acute respiratory distress syndrome using MultiStem, a somatic stem cell product for which the Company holds patent and patent licensing rights. The iPSC regenerative medicines include the creation of universal donor cells (UD), next-generation iPSCs that reduce the risk of immune rejection regardless of human leukocyte antigen (HLA) type using gene editing technology.
Fonctionnalités
Ressources
© 2026 Finture Development Limited. Tous droits réservés.
